Compounds > benidipine
Page last updated: 2024-08-24

benidipine and lysophosphatidylcholines

benidipine has been researched along with lysophosphatidylcholines in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasegawa, K; Matsubara, M1
Hasegawa, K; Matsubara, M; Yao, K1
Takayama, M; Wada, M; Yao, K1

Other Studies

3 other study(ies) available for benidipine and lysophosphatidylcholines

ArticleYear
Benidipine, a dihydropyridine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells.
    Atherosclerosis, 2005, Volume: 178, Issue:1

    Topics: Antioxidants; Aorta; Calcium Channel Blockers; Caspase 3; Caspase 7; Caspases; Cells, Cultured; Dihydropyridines; Endothelial Cells; Enzyme Activation; Humans; Lysophosphatidylcholines; Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species

2005
Benidipine, a dihydropyridine-calcium channel blocker, inhibits lysophosphatidylcholine-induced endothelial injury via stimulation of nitric oxide release.
    Pharmacological research, 2006, Volume: 53, Issue:1

    Topics: Apoptosis; Calcium Channel Blockers; Cell Line; Cytoprotection; Dihydropyridines; Endothelial Cells; Endothelium, Vascular; Humans; Lysophosphatidylcholines; Nitric Oxide; Nitric Oxide Synthase Type III; Umbilical Veins

2006
The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta.
    Journal of biomedical science, 2009, Jun-26, Volume: 16

    Topics: Administration, Oral; Animals; Antioxidants; Aorta; Calcium; Calcium Channel Blockers; Cell Membrane; Dihydropyridines; Endothelial Cells; Endothelium, Vascular; Fluorescence Recovery After Photobleaching; Lysophosphatidylcholines; Male; Rats; Rats, Sprague-Dawley

2009